» Articles » PMID: 32862324

Impaired UTP-induced Relaxation in the Carotid Arteries of Spontaneously Hypertensive Rats

Overview
Publisher Springer
Date 2020 Aug 31
PMID 32862324
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Uridine 5'-triphosphate (UTP) has an important role as an extracellular signaling molecule that regulates inflammation, angiogenesis, and vascular tone. While chronic hypertension has been shown to promote alterations in arterial vascular tone regulation, carotid artery responses to UTP under hypertensive conditions have remained unclear. The present study investigated carotid artery responses to UTP in spontaneously hypertensive rats (SHR) and control Wistar Kyoto rats (WKY). Accordingly, our results found that although UTP promotes concentration-dependent relaxation in isolated carotid artery segments from both SHR and WKY after pretreatment with phenylephrine, SHR exhibited significantly lower arterial relaxation responses compared with WKY. Moreover, UTP-induced relaxation was substantially reduced by endothelial denudation and by the nitric oxide (NO) synthase inhibitor N-nitro-L-arginine in both SHR and WKY. The difference in UTP-induced relaxation between both groups was abolished by the selective P2Y receptor antagonist AR-C118925XX and the cyclooxygenase (COX) inhibitor indomethacin but not by the thromboxane-prostanoid receptor antagonist SQ29548. Furthermore, we detected the release of PGE, PGF, and PGI in the carotid arteries of SHR and WKY, both at baseline and in response to UTP. UTP administration also increased TXA levels in WKY but not SHR. Overall, our results suggest that UTP-induced relaxation in carotid arteries is impaired in SHR perhaps due to impaired P2Y receptor signaling, reductions in endothelial NO, and increases in the levels of COX-derived vasoconstrictor prostanoids.

Citing Articles

How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.

Dales M, Drummond R, Kennedy C Purinergic Signal. 2024; .

PMID: 38740733 DOI: 10.1007/s11302-024-10016-z.


Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.

Dales M, Mitchell C, Gurney A, Drummond R, Kennedy C Purinergic Signal. 2022; 18(4):515-528.

PMID: 36018534 PMC: 9832182. DOI: 10.1007/s11302-022-09895-x.


Diabetes and hypertension: Pivotal involvement of purinergic signaling.

Reichert K, Castro M, Assmann C, Bottari N, Miron V, Cardoso A Biomed Pharmacother. 2021; 137:111273.

PMID: 33524787 PMC: 7846467. DOI: 10.1016/j.biopha.2021.111273.

References
1.
Burnstock G, Ralevic V . Purinergic signaling and blood vessels in health and disease. Pharmacol Rev. 2013; 66(1):102-92. DOI: 10.1124/pr.113.008029. View

2.
De Silva T, Kinzenbaw D, Modrick M, Reinhardt L, Faraci F . Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function. Hypertension. 2016; 68(3):809-17. PMC: 4982851. DOI: 10.1161/HYPERTENSIONAHA.116.07430. View

3.
von Kugelgen I, Hoffmann K . Pharmacology and structure of P2Y receptors. Neuropharmacology. 2015; 104:50-61. DOI: 10.1016/j.neuropharm.2015.10.030. View

4.
Denniss S, Ford R, Smith C, Jeffery A, Rush J . Chronic in vivo or acute in vitro resveratrol attenuates endothelium-dependent cyclooxygenase-mediated contractile signaling in hypertensive rat carotid artery. J Appl Physiol (1985). 2016; 120(10):1141-50. PMC: 4867319. DOI: 10.1152/japplphysiol.00675.2015. View

5.
Guns P, Korda A, Crauwels H, Van Assche T, Robaye B, Boeynaems J . Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol. 2005; 146(2):288-95. PMC: 1576272. DOI: 10.1038/sj.bjp.0706326. View